PACTR201712002788898
Other
未知
Evaluation of an antibody detecting point-of-care test for the diagnosis of Taenia solium taeniasis and (neuro)cysticercosis in communities and district hospitals of highly endemic, resource-poor areas in sub Saharan Africa, including capacity building
Institute of Tropical Medicine0 sites3,800 target enrollmentNovember 21, 2017
Conditionsneurocysticercosis, taeniosis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- neurocysticercosis, taeniosis
- Sponsor
- Institute of Tropical Medicine
- Enrollment
- 3800
- Status
- Other
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Tanzania NCC:
- •Patients 10 years of age and above with on\-going symptoms of severe progressive headache impeding the daily activities without fever and without signs of cerebral infection or other obvious causes OR patients 10 years of age and above with a history of one or more epileptic seizures without obvious causes
- •¿ Patients willing and able to participate in all aspects of the study, including providing blood and stool samples, participating in a questionnaire survey, and undergoing brain
- •CT Scan if indicated
- •¿ Patients willing and able to provide written informed consent
- •¿ Patients living in the study area for the past three months and planning to stay in the same area throughout the study period
- •Tanzania T:
- •Patient must be 10 years and above and present at the out\-patient clinic with
- •(1\) intestinal complaints compatible with intestinal worm infection (diarrhoea \> 2 weeks and/or abdominal pain/discomfort \> 2 weeks and/or recent history of worm expulsion): SELECTIVE GROUP
- •(2\) any other symptom not immediately linked with intestinal worm infection: RANDOM GROUP
Exclusion Criteria
- •Tanzania NCC:
- •¿ Patients less than 10 years of age
- •¿ Patients with any acute febrile illness
- •¿ Patients with fever and signs and symptoms for middle ear infection
- •¿ Patients with signs and symptoms of meningitis
- •¿ Patients with neck muscle pain and stiffness
- •¿ Patients with a history of stroke with neurological focal deficit
- •¿ Patients not willing or able to provide written informed consent (assent for minors)
- •¿ Patients not resident in the study area
- •¿ Patients reported pregnant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinic-based evaluation of antigen-based point-of-care tests for genital trichomoniasis infection and bacterial vaginosis among women attending antenatal care facilities in Nchelenge, ZambiaTrichomoniasis and bacterial vaginosisFertility-femalePACTR202302766902029Tropical Disease Research Centre1,021
Completed
Phase 3
The efficacy of an antigenic marker lesion for the therapeutic effect in patients with multiple, Ta/T1, G1/G2, non-muscle invasive bladder cancer (NMIBC) treated with TUR followed by IL-2 instillationon-muscle invasive bladder carcinomabladder cancer1003836410004994NL-OMON41468Vrije Universiteit Medisch Centrum66
Active, not recruiting
Not Applicable
The efficacy of an antigenic marker lesion for the therapeutic effect in patients with multiple, Ta/T1, G1/G2, non-muscle invasive bladder cancer (NMIBC) treated with TUR followed by IL-2 instillation - Incomplete TUR and IL-2EUCTR2010-020397-42-NLVUmc Dept Urology
Not yet recruiting
Not Applicable
se of certain Immunological Markers in blood to detect infection in Neonates.CTRI/2012/05/002651BECTION DICKINSON AND COMPANY100
Recruiting
Not Applicable
Point-of-care detection of Borrelia antibodies using Sofia 2 Lyme+ FIA: Comparison of finger-prick whole blood assay versus testing in serum or plasmaBorrelia infectionLyme disease10004018NL-OMON49820Quidel Corporation300